Protagenic Therapeutics Inc (PTIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PTIX | AMGN | VRTX | REGN | BMY |
| Company | Protagenic Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.3999 | 316.79 | 433.59 | 988.00 | 44.60 |
| High | 1.4000 | 316.79 | 433.59 | 988.96 | 44.60 |
| Low | 1.3100 | 316.79 | 433.59 | 966.34 | 44.60 |
| Last | 1.3895 | 316.79 | 433.59 | 978.21 | 44.60 |
| Change | +0.1395 | -2.25 | -3.90 | -6.43 | +0.05 |
| % Change | +11.16% | -0.71% | -0.89% | -0.65% | +0.11% |
| Volume | 4,800 | 4,399 | 5,978 | 593,500 | 21,066 |
| 20-Day Average Volume | 7,995 | 2,863,095 | 1,059,869 | 464,015 | 13,909,573 |
| Previous Close | 1.2500 | 319.04 | 437.49 | 984.64 | 44.55 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3575 | 291.50 | 409.52 | 931.30 | 45.31 |
| 20-Day Raw Stochastic | 36.50% | 90.62% | 88.19% | 90.55% | 20.35% |
| 20-Day Relative Strength | 51.40% | 67.04% | 65.39% | 61.32% | 36.09% |
| Weighted Alpha | -7.08 | +41.49 | +28.41 | +30.10 | -33.09 |
| Today's Opinion | 40% Buy | 72% Buy | 72% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 8% Buy | 72% Buy | 56% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 48% Buy | 56% Sell | 8% Buy | 24% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +13.89% since 05/07/24 | +1.26% since 05/09/24 | +3.48% since 05/09/24 | +2.35% since 05/08/24 | -0.31% since 05/09/24 |
| Low | 1.2193 on 05/08/24 | 307.06 on 05/13/24 | 417.50 on 05/10/24 | 956.76 on 05/09/24 | 44.30 on 05/10/24 |
| High | 1.4000 on 05/15/24 | 321.44 on 05/15/24 | 439.26 on 05/15/24 | 988.96 on 05/15/24 | 45.72 on 05/14/24 |
| 1-Month | |||||
| %Chg | -0.56% since 04/15/24 | +19.26% since 04/16/24 | +10.00% since 04/16/24 | +8.86% since 04/15/24 | -7.58% since 04/16/24 |
| Low | 1.1535 on 04/17/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 1.8000 on 04/23/24 | 322.60 on 05/03/24 | 439.26 on 05/15/24 | 988.96 on 05/15/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | +43.99% since 02/15/24 | +11.66% since 02/16/24 | +2.70% since 02/16/24 | +2.46% since 02/15/24 | -10.55% since 02/16/24 |
| Low | 0.8800 on 02/29/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 1.8700 on 03/27/24 | 322.60 on 05/03/24 | 439.26 on 05/15/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +62.51% since 11/15/23 | +17.77% since 11/16/23 | +26.41% since 11/16/23 | +23.45% since 11/15/23 | -12.27% since 11/16/23 |
| Low | 0.6797 on 12/04/23 | 260.52 on 11/21/23 | 342.64 on 11/17/23 | 785.83 on 11/16/23 | 43.33 on 05/02/24 |
| High | 1.8700 on 03/27/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,163 | 171,144,224 | 112,895,608 | 107,785,040 | 90,307,296 |
| Shares Outstanding, K | 4,435 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -5,000,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -1,680,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 0.44 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 04/01/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/20/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.72 | 28.46 | 26.53 | 42.58 |